Categories LATEST
Alphabet Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Google parent Alphabet Inc. (NASDAQ: GOOG, GOOGL) is all set to publish second-quarter 2023 earnings today at 4:00 PM ET. The market will be closely following the event, looking for updates on the search giant’s AI initiatives.
Listen to Alphabet’s Q2 2023 earnings call live and read the real-time transcript
It is estimated that Alphabet generated earnings of $1.21 per share in the June quarter, which is broadly in line with the prior-year number. Analysts are looking for a 6.1% decline in third-quarter revenues to $65.42 billion.
In the previous quarter, advertising revenue came in at $54.5 billion, unchanged year-over-year. Total revenues moved up 3% from last year to around $70 billion in the first quarter. Meanwhile, net income declined 8% to $15 billion and earnings per share dropped 5% annually to $1.17. Operating cash flow was an impressive $23.5 billion.
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications
